Harri Sintonen

University of Helsinki

Papers

2

Total Citations

118

H-Index

2

About

Harri Sintonen is a leading health economist whose work bridges surgical innovation and cost-effectiveness analysis, with a particular focus on robotic-assisted procedures. His research centers on evaluating the economic and quality-of-life outcomes of advanced surgical technologies, especially in gynecologic oncology and pelvic floor surgery. Sintonen’s major contributions include conducting rigorous cost-analyses and randomized trials that challenge assumptions about the value of robotic surgery. His 2014 systematic review and cost analysis of robot-assisted hysterectomy (71 citations) provided critical evidence on the economic implications of robotic technology in both malignant and benign conditions. He further advanced the field with a landmark randomized trial comparing laparoscopic and robotic ventral mesh rectopexy (47 citations), which assessed not only anatomical and functional outcomes but also health-related quality of life and cost-effectiveness. This work is notable for its pragmatic, patient-centered approach, offering surgeons and policymakers data-driven insights into whether robotic assistance justifies its higher costs. Sintonen’s research is essential reading for clinicians and health economists seeking to understand the real-world trade-offs of adopting expensive surgical technologies.

Research Focus

Key Achievements

2
H-Index
2
Papers
118
Total Citations
59
Avg Citations/Paper
🏆 Most Cited Paper
A systematic review and cost analysis of robot-assisted hysterectomy in malignant and benign conditions
71 citations · 2014
📈 Most Prolific Year: 2014 (1 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: University of Helsinki

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago